Cabergoline bulk supplier for pharma manufacturers

Cabergoline 0.25 mg, 0.5 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 0.25 mg, 0.5 mg

Reference Brands: Dostinex®, Cabaser®

Cabergoline is a dopamine agonist used for hyperprolactinemia and Parkinson’s disease, available in 0.25 mg and 0.5 mg tablets. Brands include Dostinex® and Cabaser®. Pharma B2B suppliers offer bulk Cabergoline from GMP-certified facilities, ensuring regulatory compliance, quality assurance, and consistent supply for global pharmaceutical distributors and hospitals.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Cabergoline? List it or send an offer →

Product Description: Cabergoline is a potent dopamine agonist used to treat hyperprolactinemia and manage symptoms in Parkinson’s disease. Available primarily as 0.25 mg and 0.5 mg oral tablets, it is marketed under brands like Dostinex® and Cabaser® in the US and EU. Cabergoline works by reducing prolactin levels through D2 receptor stimulation. Pharma B2B buyers can access Cabergoline from GMP-certified manufacturers, ensuring reliable quality, regulatory approvals (US FDA, EU GMP), and scalable bulk supply. Ideal for hospital tenders, specialty distributors, and endocrinology-focused pharmaceutical partners looking for a trusted Cabergoline source in regulated and semi-regulated markets.

Cabergoline — third party manufacturing & bulk supply

Cabergoline 0.25 mg, 0.5 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Cabergoline is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Cabergoline listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Cabergoline →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Cabergoline is listed as Tablets in 0.25 mg, 0.5 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Cabergoline is referenced against Dostinex®, Cabaser®. Reference brands are shown for identification only and remain the property of their respective trademark owners.